HealthQuill Cancer Testing
IntraBio Inc, a biotechnology company focused on rare and neurodegenerative diseases, got the US regulator’s nod for a drug to treat a certain type of Niemann-Pick disease in adults and pediatric patients weighing about 15 kilograms.
Health

Primary care clinics can help detect 10% of cancers caused by genes

HQ Team March 10, 2025: Patient screening in primary care settings can detect up to 10% of cancers caused by genes. Easily available.

Read More
Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer responds to immunotherapy drugs.
Drugs Health Pharma

NIH researchers make AI tool to read cancer responses to immunotherapy

Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer.

Read More
The FDA has approved US-based DermaSensor Inc.'s handheld wireless skin cancer detection device that is powered by artificial intelligence technology.
Drugs Medical Pharma

FDA green lights DermaSensor’s skin cancer detection device in the US

HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.

Read More